Steglatro (Ertugliflozin Tablet) 5mg

Steglatro (ertugliflozin) 5mg tablets are a prescription oral medication used to manage blood sugar levels in adults with type 2 diabetes. This SGLT2 inhibitor helps support kidney function by promoting glucose excretion. Suitable for ambient storage, it offers a 28-tablet pack size.

Strength

5mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

MSD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Steglatro (ertugliflozin) is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It belongs to the SGLT2 inhibitor class, which helps lower blood glucose by increasing sugar removal through urine. People often ask, what is ertugliflozin used for and how it supports diabetes management.

Side Effects

Steglatro (ertugliflozin) 5mg tablets may lead to increased urination and thirst as the body adjusts to removing excess sugar. Some users notice mild changes in energy levels or appetite during the first weeks of use. These effects are part of how the medication works to support metabolic balance.

Precautions & Warnings

Store Steglatro at room temperature away from moisture and heat. Keep out of reach of children and pets. Before starting, inform your healthcare provider about any kidney or liver conditions. Regular monitoring may be recommended during treatment.

Avoid Interactions

Steglatro (ertugliflozin) may interact with diuretics or medications that affect blood pressure. Alcohol use may increase the risk of dehydration or low blood sugar. Always discuss all current medications with your doctor to avoid potential interactions.

Frequently Asked Questions

Ertugliflozin is used to help manage blood sugar levels in adults with type 2 diabetes as part of a treatment plan.

Store Steglatro at room temperature in a dry place away from heat and moisture. Keep the bottle tightly closed.

Alcohol may increase the risk of dehydration or low blood sugar when combined with ertugliflozin. Discuss alcohol use with your healthcare provider.

Common effects may include increased urination, thirst, or mild changes in energy levels during early use.

Steglatro is prescribed for adults with type 2 diabetes but may not be suitable for those with certain kidney or liver conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.